Skip to content
M

Mohammad Abu-Hegazy

Publications (4)

Severe Weight Loss and Emaciation Following Topiramate Administration

Mohammad Abu-Hegazy, Abdallah M. Almarzoogi, Sultan M. Almarzoogi & Waseem Marei M. Marei · International Neuropsychiatric Disease Journal · 2017

Topiramate is an antiepileptic drug, used also for prevention of an episodic migraine. Its effects include sodium-channel-blocking activity, enhancement of cerebral GABA concentrations and antagonism of AMPA/kainate receptors, which leads to a decreased glutamate-mediated excitat...

Open access Research Article 10.9734/INDJ/2017/35961

Socio-demographic and Clinical Predictors of Co-morbid Psychiatric Disorders in Patients with Epilepsy

Mohammad Abu-Hegazy, Ibrahim Elmenshawi, Hanan Elsayed, Eman Elsheshtawy & Ramadan Abd Albr Hussein · International Neuropsychiatric Disease Journal · 2015

Background: Association between epilepsy and psychiatry has a long history that required a comprehensive care of patients with epilepsy. This would include special attention to the psychological and social consequences besides the control of seizures. Aim: This study aimed at ide...

Open access Research Article 10.9734/INDJ/2016/20542

Can Glycosylated Hemoglobin and C-reactive Protein Levels Predict Development of Subclinical Neuropathy in Pre-diabetics?

Ahmed Esmael, Mohammad Abu-Hegazy & Amr Elrabat · International Neuropsychiatric Disease Journal · 2015

Background: Individuals with elevated glycosylated hemoglobin (HbA1c) have a higher rate of microvascular complications, especially peripheral neuropathy. Objective: To  find the relation  between  elevated   (HbA1c) and the  occurrence of  peripheral  nerve dysfunction in predia...

Open access Research Article 10.9734/INDJ/2016/22316

Sodium Valproate versus Propranolol in Chronic Migraine Prophylaxis

Hossam Egila, Zeinab El-Mahdy, Ahmed Azab, Mohammad Abu-Hegazy & Ayman Abdel-Naby · International Neuropsychiatric Disease Journal · 2020

Background: There is a need for effective, well tolerated and affordable drug for chronic migraine prophylaxis in low socioeconomic countries. Objective: To study the efficacy and safety of propranolol and sodium valproate (a food and drug administration approved and widely used...

Open access Research Article 10.9734/indj/2020/v14i330130